Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) EBT: 2021-2024

Historic EBT for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to -$188.3 million.

  • Abivax's EBT fell 31.26% to -$54.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$151.6 million, marking a year-over-year decrease of 71.69%. This contributed to the annual value of -$188.3 million for FY2024, which is 18.48% down from last year.
  • Latest data reveals that Abivax reported EBT of -$188.3 million as of FY2024, which was down 18.48% from -$159.0 million recorded in FY2023.
  • In the past 5 years, Abivax's EBT ranged from a high of -$50.2 million in FY2021 and a low of -$188.3 million during FY2024.
  • In the last 3 years, Abivax's EBT had a median value of -$159.0 million in 2023 and averaged -$137.1 million.
  • Data for Abivax's EBT shows a maximum YoY tumbled of 148.31% (in 2023) over the last 5 years.
  • Abivax's EBT (Yearly) stood at -$50.2 million in 2021, then declined by 27.43% to -$64.0 million in 2022, then tumbled by 148.31% to -$159.0 million in 2023, then fell by 18.48% to -$188.3 million in 2024.